A phase 2, double-blind study of the investigational medication, brexanolone, in the treatment of women with severe PPD published in The Lancet. Clinical trials are currently underway at UNC.
Brain Health, Depression, Families, Mental Health, Pregnancy, Research, Studies, Treatment, Wellness, Women's Health
UNC Lineberger's Hazel Nichols, PhD, Chelsea Anderson, MPH, and their colleagues report that women diagnosed and treated for cancer during their childbearing years more commonly gave birth prematurely, and to babies whose weights were below normal. Cancer survivors also had a slightly higher rate of cesarean section deliveries.
Approximately 10,000 women have enrolled in PPD ACT via the iPhone app.
The advent of targeted drugs for a specific type of breast cancer – HER2 positive – has dramatically improved survival rates for women with the disease. But a study led by researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center reveals low rates of use o
Genetics ResearchKit study invites women to provide DNA samples to help researchers analyze genomic signature of postpartum depression.
A new study of newborns with prenatal drug exposure finds cocaine-specific disruptions in a part of the brain circuitry thought to play an important role in arousal regulation.
A close examination of gut bacteria reveals that exclusively breastfed babies are better equipped for the transition to solids and potentially an early life with fewer stomach woes
Martin McCaffrey, MD, CAPT, USN (Ret), has taken the lessons he learned in the Navy and applied them to helping military families as they cope with the challenges of having a newborn in the Newborn Critical Care Center at UNC Hospitals.
Postpartum depression (PPD) may have a diverse clinical presentation and this has critical implications for diagnosis, treatment and understanding the underlying biology of the illness, a new study finds.
